Stryker Director Sells $1,159,200 in Stock (SYK)
Stryker (NYSE:SYK) Director Ronda E. Stryker sold 14,000 shares of the stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $82.80, for a total value of $1,159,200.00. Following the completion of the transaction, the director now directly owns 174,605 shares in the company, valued at approximately $14,457,294. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Stryker (NYSE:SYK) traded down 0.63% on Wednesday, hitting $82.33. 592,638 shares of the company’s stock traded hands. Stryker has a 52-week low of $66.44 and a 52-week high of $86.93. The stock’s 50-day moving average is $81.54 and its 200-day moving average is $81.58. The company has a market cap of $31.169 billion and a price-to-earnings ratio of 46.28.
Stryker (NYSE:SYK) last announced its earnings results on Thursday, July 17th. The company reported $1.08 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.08. The company had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the company posted $1.00 earnings per share. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, analysts predict that Stryker will post $4.77 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date of this dividend is Friday, September 26th.
SYK has been the subject of a number of recent research reports. Analysts at Needham & Company LLC upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Tuesday, August 12th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $86.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $90.00 price target on the stock, up previously from $85.00. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $86.18.
Stryker Corporation (NYSE:SYK) is a medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.